Welcome!

News Feed Item

FONAR Announces Fiscal 2014 Second Quarter Earnings Results

MELVILLE, NY -- (Marketwired) -- 02/14/14 -- FONAR Corporation (NASDAQ: FONR),

  • Second Fiscal 2014 Quarter Net Revenues increase 83% over Second Fiscal Quarter 2013 to $17.6 million.
  • Second Fiscal 2014 Quarter Net Income increases 88% over Second Fiscal Quarter 2013 to $3.0 million
  • Diluted EPS Available to Common Stockholders for the Second Fiscal 2014 Quarter was $0.33, an increase of 57% over Second Fiscal Quarter 2013
  • FONAR records Fifthteenth straight quarter of positive Net Income and Income from Operations of which most recent ten were greater than $1.5 Million

FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, reported its second quarter, fiscal 2014 results for the quarter ended December 31, 2013. The Company's two industry segments include the management of 23 Stand-Up® MRI (UPRIGHT® MRI) centers as well as its traditional MRI development, manufacturing and service business. Its stellar product line includes the FONAR UPRIGHT® Multi-Position™ MRI (aka STAND-UP® MRI which enables full weight-bearing MRI imaging and is particularly powerful in the gravity sensitive regions of the human anatomy, e.g. the spine, brain, hip, knee, ankle, foot, shoulder, and pelvis. The FONAR UPRIGHT® Multi-Position™ MRI scanner is the world's only MRI scanner licensed under FONAR's multiple UPRIGHT® MRI patents to scan all the patient's body parts in their normal fully weight-bearing UPRIGHT® position.

Statement of Operations Items

Income from operations for the quarter ended December 31, 2013, increased 91% to $3.3 million, as compared to $1.7 million for the same period one year earlier. For the six month period ended December 31, 2013, income from operations was $7.4 million as compared to $3.6 million during the corresponding period one year earlier, an increase of 104%.

Net Income for the quarter ended December 31, 2013, increased 88% to $3.0 million, as compared to $1.6 million for the same period one year earlier. For the six month period ended December 31, 2013, net income was $6.7 million as compared to $3.4 million during the corresponding period one year earlier, an increase of 96%.

Diluted Net Income per Common Share available to Common shareholders for the quarter ended December 31, 2013 increased 57% to $0.33, as compared to $0.21 for the same period one year earlier.

For the six month period ended December 31, 2013, Diluted Net Income per Common Share available to Common shareholders increased 63% to $0.70, as compared to $0.43 for the same period one year earlier.

Total revenues for the quarter ended December 31, 2013, increased 83% to $17.6 million as compared to $9.6 million during the same period one year earlier. For the six month period ended December 31, 2013, total revenues increased 80% to $34.4 million as compared to $19.1 million, one year earlier.

Revenue from the patient fee segment and management and other fees segment, for the quarter ended December 31, 2013, increased 149% to $14.3 million, as compared to $5.7 million during the same period one year earlier. At six months this also increased 149% to $28.5 million as compared to the same period one year earlier at $11.5 million. This is the revenue that comes from patient fees and the management of the 23 FONAR Stand-Up™ MRI diagnostic imaging centers, by FONAR's HMCA subsidiary.

Balance Sheet Items

At December 31, 2013, total current assets were $43.5 million, total assets were $77.1 million, total current liabilities were $23.2 million, and total long-term liabilities were $11.8 million.

At December 31, 2013, total cash and cash equivalents were $9.4 million.

At December 31, 2013, total stockholder's equity was $42.1 million.

See the accompanying tables for more details.

Recent Significant Events

In December, 2013, the Company settled a two-year old patent infringement case brought against it. The infringement action alleged that FONAR's Upright® MRI scanners infringe plaintiff's patent which relates to the moving of a patient into the scanner. The Company took the position that the plaintiff's claims were without merit and that their patent was invalid. The parties have settled the case and while FONAR will pay $150,000, there are certain licenses and covenants not to sue again.

Management Discussion

The acquisition of Health Diagnostic Management (HDM) has been a significant source of profitability for the Company. The diluted earnings per share available for the common stockholder for the six months which ended on December 31, 2013 increased 63% to $0.70 when compared to one year earlier. The Company plans to continue to grow at a reasonable pace while maintaining its highly profitable profile."

About FONAR

FONAR (NASDAQ: FONR), Melville, NY, The Inventor of MR Scanning™, was incorporated in 1978, and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world's first commercial MRI in 1980, and went public in 1981. Since its inception, nearly 300 recumbent-OPEN MRIs and 157 UPRIGHT® Multi-Position™ MRI scanners have been installed worldwide. FONAR's stellar product is the UPRIGHT® MRI (also known as the Stand-Up® MRI), the only whole-body MRI that performs Position™ imaging (pMRI™) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT® MRI often sees the patient's problem that other scanners cannot because they are lie-down and "weightless" only scanners. The patient-friendly UPRIGHT® MRI has a near-zero claustrophobic rejection rate by patients. As a FONAR customer states, "If the patient is claustrophobic in this scanner, they'll be claustrophobic in my parking lot." Approximately 85% of patients are scanned sitting while they watch a 42" flat screen TV. FONAR is headquartered on Long Island, New York.

UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™, Full Range of Motion™, Multi-Position™, Upright Radiology™, The Proof is in the Picture™, True Flow™, pMRI™, Spondylography™, Dynamic™,Spondylometry™, CSP™, and Landscape™, are trademarks of FONAR Corporation.

This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission.



                     FONAR CORPORATION AND SUBSIDIARIES
                    CONDENSED CONSOLIDATED BALANCE SHEETS
         (AMOUNTS AND SHARES IN THOUSANDS,EXCEPT PER SHARE AMOUNTS)
                                 (UNAUDITED)

                                   ASSETS

                                                 December 31,     June 30,
ASSETS                                                2013          2013
                                                 ------------- -------------
Cash and cash equivalents                        $       9,425 $       7,871
Accounts receivable - net                                5,359         4,444
Accounts receivable - related party                         60             -
Medical receivable - net                                 8,884         8,126
Management and other fees receivable - net              12,347        11,466
Management and other fees receivable - related
 medical practices - net                                 2,985         2,382
Inventories                                              2,562         2,077
Prepaid expenses and other current assets                1,901         1,500
                                                 ------------- -------------
Total Current Assets                                    43,523        37,866

Property and equipment - net                            16,538        17,524
Goodwill                                                 1,767         1,767
Other intangible assets - net                           11,271        11,904
Deferred income tax asset                                2,936         2,936
Other assets                                             1,050         1,154
                                                 ------------- -------------
Total Assets                                     $      77,085 $      73,151
                                                 ============= =============

                    LIABILITIES AND STOCKHOLDERS' EQUITY

                                                 December 31,    June 30,
LIABILITIES                                           2013          2013
                                                 ------------- -------------
Current Liabilities:
  Current portion of long-term debt and capital
   leases                                        $       3,048 $       2,886
  Accounts payable                                       2,941         2,752
  Other current liabilities                              9,401         8,636
  Unearned revenue on service contracts                  5,725         4,965
  Unearned revenue on service contracts -
   related party                                            55             -
  Customer advances                                      2,041         1,858
  Income tax payable                                         -            20
                                                 ------------- -------------
    Total Current Liabilities                           23,211        21,117

Long-Term Liabilities:
  Due to related medical practices                         229           231
  Long-term debt and capital leases, less
   current portion                                      10,530        12,887
  Deferred income tax liability                            462           462
  Other liabilities                                        596           654
                                                 ------------- -------------
    Total Long-Term Liabilities                         11,817        14,234
                                                 ------------- -------------
    Total Liabilities                                   35,028        35,351
                                                 ------------- -------------



                     FONAR CORPORATION AND SUBSIDIARIES
                   CONDENSED CONSOLIDATED BALANCE SHEETS
         (AMOUNTS AND SHARES IN THOUSANDS,EXCEPT PER SHARE AMOUNTS)
                                (UNAUDITED)

              LIABILITIES AND STOCKHOLDERS' EQUITY (Continued)

                                                 December 31,    June 30,
STOCKHOLDERS' EQUITY:                                2013          2013
                                                 ------------  ------------
Class A non-voting preferred stock $.0001 par
 value; 453 shares authorized at December 31,
 2013 and June 30, 2013, 313 issued and
 outstanding at December 31, 2013 and June 30,
 2013                                                       -             -
Preferred stock $.001 par value; 567 shares
 authorized at December 31, 2013 and June 30,
 2013, issued and outstanding - none                        -             -
Common Stock $.0001 par value; 8,500 shares
 authorized at December 31, 2013 and June 30,
 2013, 6,022 and 5,981 issued at December 31,
 2013 and June 30, 2013, respectively; 6,010 and
 5,969 outstanding at December 31, 2013 and June
 30, 2013, respectively                                     1             1
Class B Common Stock (10 votes per share) $
 .0001 par value; 227 shares authorized at
 December 31, 2013 and June 30, 2013, .146
 issued and outstanding at December 31, 2013 and
 June 30, 2013                                              -             -
Class C Common Stock (25 votes per share) $.0001
 par value; 567 shares authorized at December
 31, 2013 and June 30, 2013, 383 issued and
 outstanding at December 31, 2013 and June 30,
 2013                                                       -             -
Paid-in capital in excess of par value                174,770       174,499
Accumulated deficit                                  (155,075)     (159,655)
Notes receivable from employee stockholders               (42)          (55)
Treasury stock, at cost - 12 shares of common
 stock at December 31, 2013 and June 30, 2013            (675)         (675)
                                                 ------------  ------------
Total Fonar Corporation Stockholder Equity             18,979        14,115
Non controlling interests                              23,078        23,685
                                                 ------------  ------------

Total Stockholders' Equity                             42,057        37,800
                                                 ------------  ------------

Total Liabilities and Stockholders' Equity       $     77,085  $     73,151
                                                 ============  ============



                     FONAR CORPORATION AND SUBSIDIARIES
                CONDENSED CONSOLIDATED STATEMENTS OF INCOME
         (AMOUNTS AND SHARES IN THOUSANDS,EXCEPT PER SHARE AMOUNTS)
                                (UNAUDITED)

                                                 FOR THE THREE MONTHS ENDED
                                                        DECEMBER 31,
                                                 --------------------------
REVENUES                                             2013          2012
                                                 ------------  ------------
  Product sales - net                            $        755  $      1,080
  Service and repair fees - net                         2,548         2,765
  Service and repair fees - related parties -
   net                                                     28            28
  Patient fee revenue, net of contractual
   allowances and discounts                             5,894             -
  Provision for bad debts for patient fee              (2,223)            -
  Management and other fees - net                       8,274         3,775
  Management and other fees - related medical
   practices - net                                      2,333         1,965
                                                 ------------  ------------
    Total Revenues - Net                               17,609         9,613
                                                 ------------  ------------

COSTS AND EXPENSES
  Costs related to product sales                          631           904
  Costs related to service and repair fees                587           894
  Costs related to service and repair fees -
   related parties                                          6             9
  Costs related to patient fee revenue                  2,028             -
  Costs related to management and other fees            5,190         2,235
  Costs related to management and other fees -
   related medical practices                            1,270           852
  Research and development                                374           320
  Selling, general and administrative                   4,352         2,352
  Provision for bad debts                                (124)          325
                                                 ------------  ------------
    Total Costs and Expenses                           14,314         7,891
                                                 ------------  ------------
Income From Operations                                  3,295         1,722
Interest Expense                                         (237)         (103)
Investment Income                                          60            60
Other Expense                                               -            (4)
                                                 ------------  ------------
Income Before Provision for Income Taxes and Non
 Controlling Interests                                  3,118         1,675
Provision for Income Taxes                                 70            55
                                                 ------------  ------------
Net Income                                              3,048         1,620
Net Income - Non Controlling Interests                   (905)         (271)
                                                 ------------  ------------
Net Income - Controlling Interests               $      2,143  $      1,349
                                                 ============  ============
Net Income Available to Common Stockholders      $      2,003  $      1,259
                                                 ============  ============
Net Income Available to Class A Non-Voting
 Preferred Stockholders                          $        104  $         67
                                                 ============  ============
Net Income Available to Class C Common
 Stockholders                                    $         36  $         23
                                                 ============  ============
Basic Net Income Per Common Share Available to
 Common Stockholders                             $       0.33  $       0.21
                                                 ============  ============
Diluted Net Income Per Common Share Available to
 Common Stockholders                             $       0.33  $       0.21
                                                 ============  ============
Basic and Diluted Income Per Share-Common C      $       0.09  $       0.06
                                                 ============  ============
Weighted Average Basis Shares Outstanding-Common
 Stockholders                                           6,006         5,926
                                                 ============  ============
Weighted Average Diluted Shares Outstanding             6,133         6,054
                                                 ============  ============
Weighted Average Basic Shares Outstanding -
 Class C                                                  383           383
                                                 ============  ============
Weighted Average Diluted Shares Outstanding -
 Class C Common                                           383           383
                                                 ============  ============



                     FONAR CORPORATION AND SUBSIDIARIES
                CONDENSED CONSOLIDATED STATEMENTS OF INCOME
        (AMOUNTS AND SHARES IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
                                (UNAUDITED)

                                                  FOR THE SIX MONTHS ENDED
                                                        DECEMBER 31,
                                                 --------------------------
                                                     2013          2012
                                                 ------------  ------------
REVENUES
  Product sales - net                            $        783  $      2,121
  Service and repair fees - net                         5,060         5,474
  Service and repair fees - related parties -
   net                                                     55            55
  Patient fee revenue, net of contractual
   allowances and discounts                            11,721             -
  Provision for bad debts for patient fee              (4,262)            -
  Management and other fees - net                      16,417         7,544
  Management and other fees - related medical
   practices - net                                      4,666         3,930
                                                 ------------  ------------
    Total Revenues - Net                               34,440        19,124
                                                 ------------  ------------

COSTS AND EXPENSES
  Costs related to product sales                          678         1,959
  Costs related to service and repair fees              1,131         1,760
  Costs related to service and repair fees -
   related parties                                         12            18
  Costs related to patient fee revenue                  3,877             -
  Costs related to management and other fees           10,264         4,406
  Costs related to management and other fees -
   related medical practices                            2,490         1,669
  Research and development                                769           650
  Selling, general and administrative                   8,089         4,564
  Provision for bad debts                                (218)          500
                                                 ------------  ------------
    Total Costs and Expenses                           27,092        15,526
                                                 ------------  ------------
Income From Operations                                  7,348         3,598
Interest Expense                                         (480)         (179)
Investment Income                                         121           120
Other Expense                                            (151)          (13)
                                                 ------------  ------------
Income Before Provision for Income Taxes and Non
 Controlling Interests                                  6,838         3,526
Provision for Income Taxes                                170           127
                                                 ------------  ------------
Net Income                                              6,668         3,399
Net Income - Non Controlling Interests                 (2,088)         (598)
                                                 ------------  ------------
Net Income - Controlling Interests               $      4,580  $      2,801
                                                 ============  ============
Net Income Available to Common Stockholders      $      4,280  $      2,616
                                                 ============  ============
Net Income Available to Class A Non-voting
 Preferred Stockholders                          $        223  $        138
                                                 ============  ============
Net Income Available to Class C Common
 Stockholders                                    $         77  $         47
                                                 ============  ============
Basic Net Income Per Common Share Available to
 Common Stockholders                             $       0.71  $       0.44
                                                 ============  ============
Diluted Net Income Per Common Share Available to
 Common Stockholders                             $       0.70  $       0.43
                                                 ============  ============
Basic and Diluted Income Per Share-Common C      $       0.20  $       0.12
                                                 ============  ============
Weighted Average Basic Shares Outstanding               5,992         5,914
                                                 ============  ============
Weighted Average Diluted Shares Outstanding             6,120         6,041
                                                 ============  ============
Weighted Average Basic Shares Outstanding -
 Class C Common                                           383           383
                                                 ============  ============
Weighted Average Diluted Shares Outstanding -
 Class C Common                                           383           383
                                                 ============  ============

Contact:
Daniel Culver
Director of Communications
E-mail: Email Contact
www.fonar.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
Column Technologies exhibited at SYS-CON's @DevOpsSummit at Cloud Expo, which took place at the Javits Center in New York City, NY, in June 2016. Established in 1998, Column Technologies is a global technology solutions provider with over 400 employees, headquartered in the United States with offices in Canada, India, and the United Kingdom. Column Technologies provides “Best of Breed” technology solutions that automate the key DevOps principals and help our customers meet today’s DevOps and Dig...
Wooed by the promise of faster innovation, lower TCO, and greater agility, businesses of every shape and size have embraced the cloud at every layer of the IT stack – from apps to file sharing to infrastructure. The typical organization currently uses more than a dozen sanctioned cloud apps and will shift more than half of all workloads to the cloud by 2018. Such cloud investments have delivered measurable benefits. But they’ve also resulted in some unintended side-effects: complexity and risk. ...
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
SYS-CON Events announced today that Outlyer, a monitoring service for DevOps and operations teams, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Outlyer is a monitoring service for DevOps and Operations teams running Cloud, SaaS, Microservices and IoT deployments. Designed for today's dynamic environments that need beyond cloud-scale monitoring, we make monitoring effortless so you...
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo 2017. The @DevOpsSummit at Cloud Expo New York will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and @DevOpsSummit at Cloud Expo Silicon Valley will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Have you ever noticed how some IT people seem to lead successful, rewarding, and satisfying lives and careers, while others struggle? IT author and speaker Don Crawley uncovered the five principles that successful IT people use to build satisfying lives and careers and he shares them in this fast-paced, thought-provoking webinar. You'll learn the importance of striking a balance with technical skills and people skills, challenge your pre-existing ideas about IT customer service, and gain new in...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend @CloudExpo | @ThingsExpo, June 6-8, 2017, at the Javits Center in New York City, NY and October 31 - November 2, 2017, Santa Clara Convention Center, CA. Learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
SYS-CON Events announced today that CrowdReviews.com has been named “Media Sponsor” of SYS-CON's 20th International Cloud Expo, which will take place on June 6–8, 2017, at the Javits Center in New York City, NY. CrowdReviews.com is a transparent online platform for determining which products and services are the best based on the opinion of the crowd. The crowd consists of Internet users that have experienced products and services first-hand and have an interest in letting other potential buyers...
DevOps and microservices are permeating software engineering teams broadly, whether these teams are in pure software shops but happen to run a business, such Uber and Airbnb, or in companies that rely heavily on software to run more traditional business, such as financial firms or high-end manufacturers. Microservices and DevOps have created software development and therefore business speed and agility benefits, but they have also created problems; specifically, they have created software securi...
@DevOpsSummit at Cloud taking place June 6-8, 2017, at Javits Center, New York City, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long developm...
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, Cloud Expo and @ThingsExpo are two of the most important technology events of the year. Since its launch over eight years ago, Cloud Expo and @ThingsExpo have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors! In this blog post, I provide 7 tips on how, as part of our world-class faculty, you can deliver one of the most popular sessions at our events. But before reading the...
While not quite mainstream yet, WebRTC is starting to gain ground with Carriers, Enterprises and Independent Software Vendors (ISV’s) alike. WebRTC makes it easy for developers to add audio and video communications into their applications by using Web browsers as their platform. But like any market, every customer engagement has unique requirements, as well as constraints. And of course, one size does not fit all. In her session at WebRTC Summit, Dr. Natasha Tamaskar, Vice President, Head of C...
In their general session at 16th Cloud Expo, Michael Piccininni, Global Account Manager - Cloud SP at EMC Corporation, and Mike Dietze, Regional Director at Windstream Hosted Solutions, reviewed next generation cloud services, including the Windstream-EMC Tier Storage solutions, and discussed how to increase efficiencies, improve service delivery and enhance corporate cloud solution development. Michael Piccininni is Global Account Manager – Cloud SP at EMC Corporation. He has been engaged in t...
Cloud Expo, Inc. has announced today that Aruna Ravichandran, vice president of DevOps Product and Solutions Marketing at CA Technologies, has been named co-conference chair of DevOps at Cloud Expo 2017. The @DevOpsSummit at Cloud Expo New York will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and @DevOpsSummit at Cloud Expo Silicon Valley will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
In the enterprise today, connected IoT devices are everywhere – both inside and outside corporate environments. The need to identify, manage, control and secure a quickly growing web of connections and outside devices is making the already challenging task of security even more important, and onerous. In his session at @ThingsExpo, Rich Boyer, CISO and Chief Architect for Security at NTT i3, will discuss new ways of thinking and the approaches needed to address the emerging challenges of securit...